Tag: Clarity Pharmaceuticals

spot_imgspot_img

Clarity Pharmaceuticals: Receives IND approval from FDA for phase 2 SAR-Bombesin imaging trial

Clarity Pharmaceuticals Receives IND approval from FDA for phase 2 SAR-Bombesin imaging trialClarity Pharmaceuticals (CU6) receives approval from the US Food and Drug...

Clarity Pharmaceuticals: Receives $3.26m R&D refund

Clarity Pharmaceuticals Receives $3.26m R&D refundClarity Pharmaceuticals (CU6) has received a research and development (R&D) tax refund of more than $3.26 million for...